NervGen Pharma Corp. (TSXV:NGEN)

NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.36	17.27	11.66	22.45	16.93	5.6
Cash & Short-Term Investments	11.36	17.27	11.66	22.45	16.93	5.6
Cash Growth	-45.91%	48.10%	-48.07%	32.62%	202.38%	36.34%
Accounts Receivable	0.03	0.1	-	-	-	-
Other Receivables	0.34	0.42	0.25	0.03	0.06	0.06
Receivables	0.38	0.51	0.25	0.03	0.06	0.06
Prepaid Expenses	0.22	0.18	0.11	0.08	0.07	0.05
Other Current Assets	0.69	1.05	0.5	0.59	0.36	0.49
Total Current Assets	12.65	19.01	12.52	23.15	17.42	6.2
Property, Plant & Equipment	-	-	0.2	0.3	0	0
Other Intangible Assets	0.42	0.46	0.52	0.43	0.47	0.47
Long-Term Accounts Receivable	-	0.01	-	-	-	-
Total Assets	13.08	19.49	13.24	23.88	17.9	6.68

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	-	-	3.32	2	0.35	0.17
Accrued Expenses	5.41	4.94	-	1.4	0.73	0.58
Current Portion of Leases	0.03	0.1	0.09	0.09	-	-
Other Current Liabilities	10.58	11.86	11.73	6.73	-	-
Total Current Liabilities	16.02	16.9	15.14	10.22	1.08	0.76
Long-Term Leases	-	0.01	0.11	0.2	-	-
Total Liabilities	16.02	16.91	15.25	10.41	1.08	0.76

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	90.48	81.1	58.93	57.41	42.4	22.95
Retained Earnings	-119.85	-102.16	-78.15	-55.77	-35.05	-22.32
Comprehensive Income & Other	26.43	23.64	17.21	11.82	9.46	5.3
Shareholders' Equity	-2.94	2.58	-2.01	13.46	16.82	5.92
Total Liabilities & Equity	13.08	19.49	13.24	23.88	17.9	6.68

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	0.03	0.11	0.2	0.28	-	-
Net Cash (Debt)	11.33	17.16	11.46	22.17	16.93	5.6
Net Cash Growth	-45.73%	49.72%	-48.29%	30.95%	202.38%	36.34%
Net Cash Per Share	0.16	0.25	0.19	0.42	0.43	0.17
Filing Date Shares Outstanding	78.34	70.99	69.93	59.13	46.23	35.86
Total Common Shares Outstanding	73.41	70.33	59.61	58.78	46.19	35.17
Working Capital	-3.36	2.11	-2.62	12.93	16.34	5.45
Book Value Per Share	-0.04	0.04	-0.03	0.23	0.36	0.17
Tangible Book Value	-3.36	2.11	-2.53	13.03	16.35	5.45
Tangible Book Value Per Share	-0.05	0.03	-0.04	0.22	0.35	0.15

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Mar 14, 2026

Data Sources Report a data error